Related Articles
High efficacy of gefitinib in the treatment of EGFR mutation‑positive advanced non‑small cell lung adenocarcinoma: A case report
Lung adenocarcinoma harboring L858R and T790M mutations in epidermal growth factor receptor, with poor response to gefitinib: A case report
Successful treatment of non‑small‑cell lung cancer with afatinib and a glucocorticoid following gefitinib‑ and erlotinib‑induced interstitial lung disease: A case report
Role of the EGFR‑KDD mutation as a possible mechanism of acquired resistance of non‑small cell lung cancer to EGFR tyrosine kinase inhibitors: A case report
Autophagic degradation of epidermal growth factor receptor in gefitinib-resistant lung cancer by celastrol